<DOC>
	<DOCNO>NCT02314871</DOCNO>
	<brief_summary>The aim study compare effect three type perioperative analgesia number circulate cancer cell ( represent minimal residual disease ) follow radical colon cancer surgery . Patients randomize one three group . The intervention group receive combine regional general anesthesia surgery postoperative epidural analgesia . The two control group receive balance general anesthesia either morphine-based piritramide-based postoperative analgesia . We hypothesize epidural analgesia favorable piritramide-based morphine-based analgesia piritramide-based analgesia favorable morphine-based analgesia regard number circulate cancer cell development early postoperative period .</brief_summary>
	<brief_title>Effects Different Types Perioperative Analgesia Minimal Residual Disease Development After Colon Cancer Surgery</brief_title>
	<detailed_description>Techniques regional analgesia epidural analgesia may favorably influence metastasis development follow cancer surgery compare analgesia base strong opioids morphine piritramide . These beneficial effect , present , probably attributable less immunosuppression antimetastatic immune defense . The aim study identify technique perioperative analgesia potential prevent metastasis development patient undergo open radical colon cancer surgery . In early postoperative period , relationship metastasis development number circulate cancer cell represent minimal residual disease show . Therefore , effect epidural , morphine-based piritramide-based analgesia number circulate cancer cell compare several time point peroperative early postoperative period . The number circulate cancer cell assess peripheral venous blood sample use real-time polymerase chain reaction . Perioperative care standardize patient follow clinical observation , laboratory analysis monitor instrumentation daily hospital stay .</detailed_description>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Neoplasm , Residual</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Pirinitramide</mesh_term>
	<criteria>Patients undergo open radical surgery colon cancer ( without know extension beyond colon ) Age 18 year Written inform consent Allergy intolerance morphine , piritramide , marcaine , sufentanil volatile anesthetic History colon cancer resection Other cancer present ( apart complete longterm remission minimum 6 month ) Chronic opioid medication and/or opioid administration 7 day less prior surgery Any contraindication thoracic epidural anesthesia/analgesia Systemic therapy immunosuppressive drug corticoid ( apart topical inhalational ) Any surgery within last 30 day ( apart minor daycase procedure ) ￼￼￼￼￼ Chronic acute infectious disease , particularly hepatitis , AIDS , tuberculosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>perioperative analgesia</keyword>
	<keyword>minimal residual disease</keyword>
	<keyword>cancer recurrence</keyword>
	<keyword>epidural</keyword>
	<keyword>morphine</keyword>
	<keyword>piritramide</keyword>
	<keyword>colon</keyword>
	<keyword>cancer</keyword>
	<keyword>circulate cancer cell</keyword>
	<keyword>colon cancer surgery</keyword>
</DOC>